Zokinvy (lonafarnib)

**Product type:** Human Prescription Drug

**Active ingredient:** LONAFARNIB

**Strength:** 75 mg/1

**Dosage form:** Capsule

**Route:** Oral

**Labeler:** Sentynl Therapeutics, Inc.

**Marketing category:** NDA (NDA213969)

**Pharmacologic class:** Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Farnesyltransferase Inhibitor [EPC], Farnesyltransferase Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]